Journal
CHEST
Volume 137, Issue 1, Pages 185-194Publisher
ELSEVIER
DOI: 10.1378/chest.08-2535
Keywords
-
Categories
Funding
- Novo-Nordisc and Eli Lilly
- Sanofi-Aventis
Ask authors/readers for more resources
This manuscript provides an overview of how to interpret in vitro clotting studies and how to select studies to evaluate patients with bleeding disorders in the ICU. It provides a practical approach to understanding the complex subject of clotting factor abnormalities, including the most common problems of preanalytical error and anticoagulation therapy. Limitations and pitfalls of diagnostic testing are highlighted. CHEST 2010; 137(1):185-194
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available